Innovex price target lowered to $13 from $16 at Barclays

Barclays analyst Eddie Kim lowered the firm’s price target on Innovex (INVX) to $13 from $16 and keeps an Underweight rating on the shares. The company reported a solid Q1 and guided Q1 EBITDA in line, the analyst tells investors in a research note. Despite no guidance for the second half of 2025, the firm expects Innovex’s financials to decline in the back half of the year.